Bio Expo Online
18.09.2008 BioServe Introduces Customizable DNA Panels for Genetic Research:
BELTSVILLE, MD — September 11, 2008 — BioServe today announced a more affordable pricing plan for its vast bank of DNA with comprehensive, de-identified, covariate data that includes age, gender, diet, body mass index (BMI), and race. In addition, each sample has data on the complete diagnostic and treatment history of the donor. BioServe’s DNA […]
18.09.2008 Colon Cancer Oncogene Discovered:
SUNDAY, Sept. 14 (HealthDay News) — Researchers have identified a new genetic player in the development of colon cancer.
The findings implicate CDK8, a protein that regulates gene expression in the proliferation of colorectal cancer, the researchers found.
Should the results be validated, they could lead to new therapeutic approaches for colon cancer, as well as new […]
18.09.2008 deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer:
Detection may be used to complement and target screening for the disease; findings will be integrated into the deCODEme(TM) personal genome scan.
Last update: 1:30 p.m. EDT Sept. 14, 2008
REYKJAVIK, Iceland, Sept 14, 2008
DCGN and colleagues at Radboud University Medical Center in the Netherlands today report the discovery of two common single-letter variants in the human […]
18.09.2008 First of 100 Arab Human Genomes Sequenced by Saudi Biosciences, Beijing Genomics Institute Shenzhen, and CLC bio:
Riyadh, Kingdom of Saudi Arabia — September 9, 2008 — An international consortium consisting of Saudi Biosciences, Beijing Genomics Institute Shenzhen, and CLC bio have in a joint effort performed an initial sequencing and analysis of the first Arab human genome, as part of a large project to sequence 100 Arab […]
04.09.2008 TOCRIS SIGNS EXCLUSIVE DEAL TO SUPPLY GEFITINIB:
September 4th, 2008 - Tocris Bioscience announced today the signing of an exclusive deal with AstraZeneca to supply Gefitinib (also known as Iressa and ZD1839) to preclinical researchers working on the mechanisms underlying cancer development. For the first time, scientists will be able to buy authentic, fully licensed, non-formulated Gefitinib as an off-the shelf product […]
02.09.2008 BIO-Europe 2008: The World’s Leading Biotech Companies and Deal-Makers Get Ready for Three Days of Intense Partnering in Mannheim/Heidelberg:
CARLSBAD, Calif. & WASHINGTON — September 2, 2008 — The leaders of the biotechnology industry will once again gather for BIO-Europe, the world’s largest stand-alone partnering conference, in Mannheim/Heidelberg, Germany, November 17-19. With biotech deal-making still the thrill in drug development markets, this year’s BIO-Europe promises to set new standards for generating quality partnering meetings […]
18.09.2008 New drug slows down cancer:
WA researchers have taken the first step towards developing new anti-cancer medications that could activate a gene shown to block the growth of cancerous cells.
Led by Western Australian Institute for Medical Research (WAIMR) Director Professor Peter Klinken, the scientists have screened a large collection of drug-like molecules and recently identified a number of compounds which […]
new | february 2007 | january 2007 | september 2006 | august 2006 | july 2006 | june 2006 | may 2006 | april 2006 | march 2006 | january 2006 | november 2005 | august 2005 | july 2005 | june 2005 | may 2005 | april 2005 | march 2005 | december 2005 | november 2004